Dr. Herrmann discusses how to monitor and treat cardiotoxicity in cancer patients receiving VEGF inhibitors.
Joerg Herrmann, MD
Advertisement
Articles by Joerg Herrmann, MD
Advertisement
Latest Updated Articles
Detecting Cardiotoxicity in Cancer Patients Receiving VEGF InhibitorsPublished: February 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC
2
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
3
Cognitive Function Improvements Highlighted With Acupuncture Use in Breast Cancer
4
QOL Improvement in Breast Cancer Noted With YES System
5
